UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

FGF19- FGFR4 Signaling in Hepatocellular Carcinoma

Cells (Basel, Switzerland), 2019-06, Vol.8 (6), p.536

2019

Volltextzugriff (PDF)

Systemic treatment for advanced urothelial cancer: an update on recent clinical trials and current treatment options

The Korean Journal of Internal Medicine, 2020, 35(4), , pp.834-853

2020

Volltextzugriff (PDF)

Evaluation of sarcopenia in small-cell lung cancer patients by routine chest CT

Supportive care in cancer, 2016-11, Vol.24 (11), p.4721-4726

2016

Volltextzugriff (PDF)

Macrophage inhibitory cytokine-1 aggravates diet-induced gallstone formation via increased ABCG5/ABCG8 expression

PloS one, 2023-06, Vol.18 (6), p.e0287146-e0287146

2023

Volltextzugriff (PDF)

The Relationship between Sarcopenia and Systemic Inflammatory Response for Cancer Cachexia in Small Cell Lung Cancer

PloS one, 2016-08, Vol.11 (8), p.e0161125-e0161125

2016

Volltextzugriff (PDF)

Prognostic Significance of Modified Advanced Lung Cancer Inflammation Index (ALI) in Patients with Small Cell Lung Cancer_ Comparison with Original ALI

PloS one, 2016-10, Vol.11 (10), p.e0164056-e0164056

2016

Volltextzugriff (PDF)

An Increasing Trend in the Number of Anterior Cruciate Ligament Reconstruction in Korea: A Nationwide Epidemiologic Study

Clinics in Orthopedic Surgery, 2022, 14(2), , pp.220-226

2022

Volltextzugriff (PDF)

Long-term response of metastatic hereditary leiomyomatosis and renal cell carcinoma syndrome associated renal cell carcinoma to bevacizumab plus erlotinib after temsirolimus and axitinib treatment failures

BMC urology, 2019-06, Vol.19 (1), p.51-5, Article 51

2019

Volltextzugriff (PDF)

AHCC ® , a Standardized Extract of Cultured Lentinula Edodes Mycelia, Promotes the Anti-Tumor Effect of Dual Immune Checkpoint Blockade Effect in Murine Colon Cancer

Frontiers in immunology, 2022-04, Vol.13, p.875872-875872

2022

Volltextzugriff (PDF)

Bevacizumab Plus Erlotinib Combination Therapy for Advanced Hereditary Leiomyomatosis and Renal Cell Carcinoma-Associated Renal Cell Carcinoma: A Multicenter Retrospective Analysis in Korean Patients

Cancer Research and Treatment, 2019, 51(4), , pp.1549-1556

2019

Volltextzugriff (PDF)

FGFR1 expression defines clinically distinct subtypes in pancreatic cancer

Journal of translational medicine, 2018-12, Vol.16 (1), p.374-7, Article 374

2018

Volltextzugriff (PDF)

The clinical implications of G1-G6 transcriptomic signature and 5-gene score in Korean patients with hepatocellular carcinoma

BMC cancer, 2018-05, Vol.18 (1), p.571-571, Article 571

2018

Volltextzugriff (PDF)

Genotypic and Phenotypic Characteristics of Hereditary Leiomyomatosis and Renal Cell Cancer Syndrome in Korean Patients

Annals of Laboratory Medicine, 2021, 41(2), , pp.207-213

2021

Volltextzugriff (PDF)

Risk factors for selection of patients at high risk of recurrence or death after complete surgical resection in stage I gastric cancer

Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2016-01, Vol.19 (1), p.226-233

2016

Volltextzugriff (PDF)

Genomics of drug sensitivity in bladder cancer: an integrated resource for pharmacogenomic analysis in bladder cancer

BMC medical genomics, 2018-10, Vol.11 (1), p.88-88, Article 88

2018

Volltextzugriff (PDF)

A phase II study of neoadjuvant docetaxel, oxaliplatin, and S-1 (DOS) chemotherapy followed by surgery and adjuvant S-1 chemotherapy in potentially resectable gastric or gastroesophageal junction adenocarcinoma

Cancer chemotherapy and pharmacology, 2013-10, Vol.72 (4), p.815-823

2013

Volltextzugriff (PDF)

Epidermal growth factor receptor (EGFR) exon 20 mutations in non-small-cell lung cancer and resistance to EGFR-tyrosine kinase inhibitors

Investigational new drugs, 2014-12, Vol.32 (6), p.1311-1315

2014

Volltextzugriff (PDF)

Phase I and pharmacodynamic study of vorinostat combined with capecitabine and cisplatin as first-line chemotherapy in advanced gastric cancer

Investigational new drugs, 2014-04, Vol.32 (2), p.271-278

2014

Volltextzugriff (PDF)

2020 Korean guidelines for the management of metastatic prostate cancer

The Korean Journal of Internal Medicine, 2021, 36(3), , pp.491-514

2021

Volltextzugriff (PDF)

Unusual radiologic manifestation of pseudoprogression in pulmonary metastases after durvalumab treatment in metastatic bladder urothelial cancer

Thoracic cancer, 2019-04, Vol.10 (4), p.1016-1018

2019

Volltextzugriff (PDF)

A randomized phase II study of weekly docetaxel/cisplatin versus weekly docetaxel/oxaliplatin as first-line therapy for patients with advanced gastric cancer

Cancer chemotherapy and pharmacology, 2014, Vol.73 (1), p.163-169

2014

Volltextzugriff (PDF)

Non-surgical treatment versus radical esophagectomy for clinical T1N0M0 esophageal carcinoma: a single-center experience

Cancer chemotherapy and pharmacology, 2014-11, Vol.74 (5), p.995-1003

2014

Volltextzugriff (PDF)

Comparative effectiveness of palliative chemotherapy versus neoadjuvant chemotherapy followed by radical cystectomy versus cystectomy followed by adjuvant chemotherapy versus cystectomy for regional node‐positive bladder cancer: A retrospective analysis: KCSG GU 17‐03

Cancer medicine (Malden, MA), 2019-09, Vol.8 (12), p.5431-5437

2019

Volltextzugriff (PDF)

Outcomes of systemic treatment in patients with metastatic pheochromocytoma and paraganglioma: A single center retrospective analysis

Journal of clinical oncology, 2023-02, Vol.41 (6_suppl), p.2-2

2023

Volltextzugriff (PDF)

Comparison of three risk stratification models for non-clear cell renal cell carcinoma patients treated with temsirolimus as first-line therapy

The Korean Journal of Internal Medicine, 2020, 35(1), , pp.185-193

2020

Volltextzugriff (PDF)

1 – 25 von 145

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(132)
Mit Volltextzugriff
(128)

Publikationsform

Sprache

Englisch
(139)
Koreanisch
(6)

Erscheinungsjahr

n.n

Thema

Science & Technology
(88)
Life Sciences & Biomedicine
(81)
Humans
(65)
Oncology
(64)
Female
(51)
Male
(51)
Aged
(44)
Middle Aged
(43)
Adult
(35)
Retrospective Studies
(32)
Aged, 80 And Over
(24)
Medicine
(24)
Medicine & Public Health
(23)
Cancer Research
(20)
Prognosis
(20)
Treatment Outcome
(20)
Tumors
(18)
Chemotherapy
(17)
Pharmacology & Pharmacy
(15)
Carcinoma, Renal Cell - Drug Therapy
(14)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

FGF19- FGFR4 Signaling in Hepatocellular Carcinoma

Systemic treatment for advanced urothelial cancer: an update on recent clinical trials and current treatment options

Evaluation of sarcopenia in small-cell lung cancer patients by routine chest CT

Macrophage inhibitory cytokine-1 aggravates diet-induced gallstone formation via increased ABCG5/ABCG8 expression

The Relationship between Sarcopenia and Systemic Inflammatory Response for Cancer Cachexia in Small Cell Lung Cancer

Prognostic Significance of Modified Advanced Lung Cancer Inflammation Index (ALI) in Patients with Small Cell Lung Cancer_ Comparison with Original ALI

An Increasing Trend in the Number of Anterior Cruciate Ligament Reconstruction in Korea: A Nationwide Epidemiologic Study

Long-term response of metastatic hereditary leiomyomatosis and renal cell carcinoma syndrome associated renal cell carcinoma to bevacizumab plus erlotinib after temsirolimus and axitinib treatment failures

AHCC ® , a Standardized Extract of Cultured Lentinula Edodes Mycelia, Promotes the Anti-Tumor Effect of Dual Immune Checkpoint Blockade Effect in Murine Colon Cancer

Bevacizumab Plus Erlotinib Combination Therapy for Advanced Hereditary Leiomyomatosis and Renal Cell Carcinoma-Associated Renal Cell Carcinoma: A Multicenter Retrospective Analysis in Korean Patients

FGFR1 expression defines clinically distinct subtypes in pancreatic cancer

The clinical implications of G1-G6 transcriptomic signature and 5-gene score in Korean patients with hepatocellular carcinoma

Genotypic and Phenotypic Characteristics of Hereditary Leiomyomatosis and Renal Cell Cancer Syndrome in Korean Patients

Risk factors for selection of patients at high risk of recurrence or death after complete surgical resection in stage I gastric cancer

Genomics of drug sensitivity in bladder cancer: an integrated resource for pharmacogenomic analysis in bladder cancer

A phase II study of neoadjuvant docetaxel, oxaliplatin, and S-1 (DOS) chemotherapy followed by surgery and adjuvant S-1 chemotherapy in potentially resectable gastric or gastroesophageal junction adenocarcinoma

Epidermal growth factor receptor (EGFR) exon 20 mutations in non-small-cell lung cancer and resistance to EGFR-tyrosine kinase inhibitors

Phase I and pharmacodynamic study of vorinostat combined with capecitabine and cisplatin as first-line chemotherapy in advanced gastric cancer

2020 Korean guidelines for the management of metastatic prostate cancer

Unusual radiologic manifestation of pseudoprogression in pulmonary metastases after durvalumab treatment in metastatic bladder urothelial cancer

A randomized phase II study of weekly docetaxel/cisplatin versus weekly docetaxel/oxaliplatin as first-line therapy for patients with advanced gastric cancer

Non-surgical treatment versus radical esophagectomy for clinical T1N0M0 esophageal carcinoma: a single-center experience

Comparative effectiveness of palliative chemotherapy versus neoadjuvant chemotherapy followed by radical cystectomy versus cystectomy followed by adjuvant chemotherapy versus cystectomy for regional node‐positive bladder cancer: A retrospective analysis: KCSG GU 17‐03

Outcomes of systemic treatment in patients with metastatic pheochromocytoma and paraganglioma: A single center retrospective analysis

Comparison of three risk stratification models for non-clear cell renal cell carcinoma patients treated with temsirolimus as first-line therapy

Suchergebnisse filtern